Pranzatelli MR: Antidyskinetic drug therapy for pediatric movement disorders. J Child Neurol1996;11:355-369.
2.
Nygaard TG: Dopa-responsive dystonia; delineation of the clinical syndrome and clues to pathogenesis. Adv Neurol1993; 60:577-585.
3.
Nygaard TG, Wilhelmsen KC, Risch NJ, et al: Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q. Nat Genet1993;5:386-391.
4.
Goetz CG, Tanner CM, Wilson RS, et al: Clonidine and Gilles de la Tourette's syndrome: Double-blind study using objective rating methods. Ann Neurol1987;21:307-310.
5.
Comings DE, Comings BG, Tacket T., et al: The clonidine patch and behavior problems. J Am Acad Child Adolesc Psychiatry1990; 29:667.
6.
Jankovic J.: Botulinum toxin in the treatment of tics associated with Tourette syndrome . Neurology1993;43(Suppl 2):A310.
7.
Scott BL, Evans RW, Jankovic J.: Sumatriptan in the treatment of essential palatal myoclonus. Neurology1996;46(Suppl 2):A261.
8.
Nemni R., Braghi S., Natali-Sora MG, et al: Autoantibodies to glutamatic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol1994;36:665-667.
9.
Demikiran M. , Jankovic J.: Paroxysmal dyskinesias: Clinical features and classification. Ann Neurol1995 ;38:571-579.
10.
Lombroso CT : Paroxysmal (kinesigenic) choreoathetosis: First case report of an invasive EEG/video investigation. Neurology1996;46(Suppl 2):A259.
11.
Papa SM, Chase TN: Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys. Ann Neurol1996;39:574-578.
12.
Kurth MC, Kopyov 0, Jacques DB: Improvement in motor function after fetal transplantation in a patient with Huntington's disease. Neurology1996;46(Suppl 2):A274.
